NPH (neutral protamine Hagedorn) insulin is a medication used to treat and manage diabetes mellitus, which is a significant risk factor for coronary artery disease. Most cases are not attributable to any specific etiology. This activity reviews the indications, contraindications, activity, adverse events, and other key elements of NPH insulin therapy in the clinical setting as relates to the essential points needed by members of an interprofessional team managing the care of patients with diabetes mellitus and its related conditions and sequelae.

**Objectives:**
- Describe the mechanism of action of NPH insulin.
- Summarize the adverse effects and contraindications of NPH insulin.
- Describe appropriate monitoring and toxicity of NPH insulin.
- Outline and explain interprofessional team strategies for improving care coordination and communication to advance NPH insulin and improve outcomes.